Reprogramming of the HepG2 genome by long interspersed nuclear element-1

Molecular Oncology

Volumn 7, Issue 4, 2013, Pages 812-825

  Bojang, Pasano ^a   Roberts, Ruth A ^b   Anderton, Mark J ^b   Ramos, Kenneth S ^a,c  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b ASTRAZENECA   (United Kingdom)

^c University of Louisville School of Medicine   (United States)

Author keywords

Epithelial to mesenchymal transition; Genetic reprogramming; Long interspersed nuclear element 1; Retrotransposons; Reverse transcriptase

Indexed keywords

CELLUBREVIN; CHITINASE; CXCL1 CHEMOKINE; CYSTEINE DIOXYGENASE; GLUTATHIONE TRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INTERCELLULAR ADHESION MOLECULE 1; LONG INTERSPERSED NUCLEAR ELEMENT 1; OCCLUDIN; PHENYLALANINE 4 MONOOXYGENASE; PROTEIN TYROSINE PHOSPHATASE; RGS PROTEIN; RNA DIRECTED DNA POLYMERASE; SYNTENIN; UNCLASSIFIED DRUG; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1; VIMENTIN;

ARTICLE; CELL ADHESION; CELL METABOLISM; CELL STRAIN HEPG2; DNA METHYLATION; GENE EXPRESSION; GENE INTERACTION; GENOME; HUMAN; HUMAN CELL; NERVE CELL PLASTICITY; NUCLEAR REPROGRAMMING; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RNA BINDING; STABLE TRANSFECTION; VECTOR CONTROL;

EPITHELIAL-TO-MESENCHYMAL TRANSITION; GENETIC REPROGRAMMING; LONG INTERSPERSED NUCLEAR ELEMENT-1; RETROTRANSPOSONS; REVERSE TRANSCRIPTASE;

FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEP G2 CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; RETROELEMENTS;

EID: 84880748103     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2013.04.003     Document Type: Article

References (47)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Ashworth A., Skene B., Swift S., Lovell-Badge R. Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene. Embo J. 1990, 9:1529-1534.
3. Baccarelli A., Wright R., Bollati V., Litonjua A., Zanobetti A., Tarantini L., Sparrow D., Vokonas P., Schwartz J. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 2010, 21:819-828.
4. Beck C.R., Garcia-Perez J.L., Badge R.M., Moran J.V. LINE-1 elements in structural variation and disease. Annu. Rev. Genom. Hum. Genet. 2011, 12:187-215.
5. Brennecke J., Aravin A.A., Stark A., Dus M., Kellis M., Sachidanandam R., Hannon G.J. Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell 2007, 128:1089-1103.
6. Brooks A.R., Harkins R.N., Wang P., Qian H.S., Liu P., Rubanyi G.M. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J. Gene Med. 2004, 6:395-404.
7. Carmell M.A., Girard A., van de Kant H.J., Bourc'his D., Bestor T.H., de Rooij D.G., Hannon G.J. MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev. Cell 2007, 12:503-514.
8. Dombroski B.A., Mathias S.L., Nanthakumar E., Scott A.F., Kazazian H.H. Isolation of an active human transposable element. Science 1991, 254:1805-1808.
9. Feng Q., Moran J.V., Kazazian H.H., Boeke J.D. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 1996, 87:905-916.
10. Ferrigno O., Virolle T., Djabari Z., Ortonne J.P., White R.J., Aberdam D. Transposable B2 SINE elements can provide mobile RNA polymerase II promoters. Nat. Genet. 2001, 28:77-81.
11. Goodier J.L., Kazazian H.H. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 2008, 135:23-35.
12. Goodier J.L., Ostertag E.M., Engleka K.A., Seleme M.C., Kazazian H.H. A potential role for the nucleolus in L1 retrotransposition. Hum. Mol. Genet. 2004, 13:1041-1048.
13. Goodier J.L., Zhang L., Vetter M.R., Kazazian H.H. LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol. Cell. Biol. 2007, 27:6469-6483.
14. Hata K., Sakaki Y. Identification of critical CpG sites for repression of L1 transcription by DNA methylation. Gene 1997, 189:227-234.
15. Hohjoh H., Singer M.F. Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA. Embo J. 1996, 15:630-639.
16. Houwing S., Kamminga L.M., Berezikov E., Cronembold D., Girard A., van den Elst H., Filippov D.V., Blaser H., Raz E., Moens C.B., Plasterk R.H., Hannon G.J., Draper B.W., Ketting R.F. A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in Zebrafish. Cell 2007, 129:69-82.
17. Islam T.C., Bugge T.H., Bohm S. The long terminal repeat of VL30 retrotransposons contains sequences that determine retinoic acid-induced transcription in cultured keratinocytes. J.Biol. Chem. 1993, 268:3251-3259.
18. Jennen D.G., Magkoufopoulou C., Ketelslegers H.B., van Herwijnen M.H., Kleinjans J.C., van Delft J.H. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol. Sci. 2010, 115:66-79.
19. Kim S., Dougherty E.R., Chen Y., Sivakumar K., Meltzer P., Trent J.M., Bittner M. Multivariate measurement of gene expression relationships. Genomics 2000, 67:201-209.
20. Kolosha V.O., Martin S.L. Invitro properties of the first ORF protein from mouse LINE-1 support its role in ribonucleoprotein particle formation during retrotransposition. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:10155-10160.
21. Korenberg J.R., Rykowski M.C. Human genome organization: Alu, lines, and the molecular structure of metaphase chromosome bands. Cell 1988, 53:391-400.
22. Kuo K.W., Sheu H.M., Huang Y.S., Leung W.C. Expression of transposon LINE-1 is relatively human-specific and function of the transcripts may be proliferation-essential. Biochem. Biophys. Res. Commun. 1998, 253:566-570.
23. Lander E.S. The new genomics: global views of biology. Science 1996, 274:536-539.
24. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
25. Lee E., Iskow R., Yang L., Gokcumen O., Haseley P., Luquette L.J., Lohr J.G., Harris C.C., Ding L., Wilson R.K., Wheeler D.A., Gibbs R.A., Kucherlapati R., Lee C., Kharchenko P.V., Park P.J. Landscape of somatic retrotransposition in human cancers. Science 2012, 337:967-971.
26. Levin H.L., Moran J.V. Dynamic interactions between transposable elements and their hosts. Nat. Rev. Genet. 2011, 12:615-627.
27. Lu K.P., Ramos K.S. Redox regulation of a novel L1Md-A2 retrotransposon in vascular smooth muscle cells. J.Biol. Chem. 2003, 278:28201-28209.
28. Martin S.L. Nucleic acid chaperone properties of ORF1p from the non-LTR retrotransposon, LINE-1. RNA Biol. 2010, 7:706-711.
29. Mathias S.L., Scott A.F., Kazazian H.H., Boeke J.D., Gabriel A. Reverse transcriptase encoded by a human transposable element. Science 1991, 254:1808-1810.
30. McClintock B. The significance of responses of the genome to challenge. Science 1984, 226:792-801.
31. Montoya-Durango D.E., Ramos K.S. L1 retrotransposon and retinoblastoma: molecular linkages between epigenetics and cancer. Curr. Mol. Med. 2010, 10:511-521.
32. Montoya-Durango D.E., Liu Y., Teneng I., Kalbfleisch T., Lacy M.E., Steffen M.C., Ramos K.S. Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins. Mutat. Res. 2009, 665:20-28.
33. Moran J.V., Holmes S.E., Naas T.P., DeBerardinis R.J., Boeke J.D., Kazazian H.H. High frequency retrotransposition in cultured mammalian cells. Cell 1996, 87:917-927.
34. Piskareva O., Schmatchenko V. DNA polymerization by the reverse transcriptase of the human L1 retrotransposon on its own template invitro. FEBS Lett. 2006, 580:661-668.
35. Ramos K.S., He Q., Kalbfleisch T., Montoya-Durango D.E., Teneng I., Stribinskis V., Brun M. Computational and biological inference of gene regulatory networks of the LINE-1 retrotransposon. Genomics 2007, 90:176-185.
36. Ramos K.S., Montoya-Durango D.E., Teneng I., Nanez A., Stribinskis V. Epigenetic control of embryonic renal cell differentiation by L1 retrotransposon. Birth Defects Res. A, Clin. Mol. Teratol. 2011, 91:693-702.
37. Schiff R., Itin A., Keshet E. Transcriptional activation of mouse retrotransposons invivo: specific expression in steroidogenic cells in response to trophic hormones. Genes Dev. 1991, 5:521-532.
38. Sciamanna I., Landriscina M., Pittoggi C., Quirino M., Mearelli C., Beraldi R., Mattei E., Serafino A., Cassano A., Sinibaldi-Vallebona P., Garaci E., Barone C., Spadafora C. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene 2005, 24:3923-3931.
39. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol. Cell. Biol. 2001, 21:1973-1985.
40. Stribinskis V., Ramos K.S. Activation of human long interspersed nuclear element 1 retrotransposition by benzo(a)pyrene, an ubiquitous environmental carcinogen. Cancer Res. 2006, 66:2616-2620.
41. Swergold G.D. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol. Cell. Biol. 1990, 10:6718-6729.
42. Takaori-Kondo A. APOBEC family proteins: novel antiviral innate immunity. Int. J. Hematol. 2006, 83:213-216.
43. Teneng I., Stribinskis V., Ramos K.S. Context-specific regulation of LINE-1. Genes Cells 2007, 12:1101-1110.
44. Teneng I., Montoya-Durango D.E., Quertermous J.L., Lacy M.E., Ramos K.S. Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation. Epigenetics 2011, 6:355-367.
45. Ting C.N., Rosenberg M.P., Snow C.M., Samuelson L.C., Meisler M.H. Endogenous retroviral sequences are required for tissue-specific expression of a human salivary amylase gene. Genes Dev. 1992, 6:1457-1465.
46. Tomilin N.V. Control of genes by mammalian retroposons. Int. Rev. Cytol. 1999, 186:1-48.
47. Yang N., Zhang L., Zhang Y., Kazazian H.H. An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res. 2003, 31:4929-4940.